Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Cash from Operations: 2011-2024

Historic Cash from Operations for Mimedx Group (MDXG) over the last 14 years, with Dec 2024 value amounting to $67.1 million.

  • Mimedx Group's Cash from Operations rose 49.45% to $29.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $67.8 million, marking a year-over-year increase of 17.72%. This contributed to the annual value of $67.1 million for FY2024, which is 92.14% up from last year.
  • Latest data reveals that Mimedx Group reported Cash from Operations of $67.1 million as of FY2024, which was up 92.14% from $34.9 million recorded in FY2023.
  • Mimedx Group's 5-year Cash from Operations high stood at $67.1 million for FY2024, and its period low was -$30.3 million during FY2020.
  • Moreover, its 3-year median value for Cash from Operations was $34.9 million (2023), whereas its average is $28.1 million.
  • Per our database at Business Quant, Mimedx Group's Cash from Operations plummeted by 81.21% in 2022 and then surged by 295.26% in 2023.
  • Mimedx Group's Cash from Operations (Yearly) stood at -$30.3 million in 2020, then skyrocketed by 67.37% to -$9.9 million in 2021, then plummeted by 81.21% to -$17.9 million in 2022, then skyrocketed by 295.26% to $34.9 million in 2023, then spiked by 92.14% to $67.1 million in 2024.